Old Web
English
Sign In
Acemap
>
authorDetail
>
Takehiro Hirai
Takehiro Hirai
Daiichi Sankyo
Biology
Immunology
Cancer
In vivo
Topoisomerase-I Inhibitor
5
Papers
291
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Reforms of regulatory pathways for approval of new antineoplastic drugs in Japan from 2004 to 2019 and accompanying changes in pivotal clinical trial designs.
2021
Investigational New Drugs
Takehiro Hirai
Asuka Suzuki
Takao Yamori
Masaaki Matsuura
Show All
Source
Cite
Save
Citations (0)
DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1
2016
Clinical Cancer Research
Yusuke Ogitani
Tetsuo Aida
Katsunobu Hagihara
Junko Yamaguchi
Chiaki Ishii
Naoya Harada
Masako Soma
Hiromi Okamoto
Masataka Oitate
Shingo Arakawa
Takehiro Hirai
Ryo Atsumi
Takashi Nakada
Ichiro Hayakawa
Yuki Abe
Toshinori Agatsuma
Show All
Source
Cite
Save
Citations (244)
Abstract A145: DS-8201a, a novel HER2-targeting ADC with a novel DNA topoisomerase I inhibitor, demonstrates a potent anti-tumor efficacy with differentiation from T-DM1 in preclinical studies
2015
Molecular Cancer Therapeutics
Yusuke Ogitani
Junko Yamaguchi
Chiaki Ishii
Takehiro Hirai
Ryo Atsumi
Koji Morita
Ichiro Hayakawa
Hiroyuki Naito
Takeshi Masuda
Takashi Nakada
Takahiro Jikoh
Show All
Source
Cite
Save
Citations (1)
Developing a practical toxicogenomics data analysis system utilizing open-source software.
2013
Methods of Molecular Biology
Takehiro Hirai
Naoki Kiyosawa
Show All
Source
Cite
Save
Citations (2)
Siglec-15, a member of the sialic acid-binding lectin, is a novel regulator for osteoclast differentiation
2011
Biochemical and Biophysical Research Communications
Yoshiharu Hiruma
Takehiro Hirai
Eisuke Tsuda
Show All
Source
Cite
Save
Citations (44)
1